A detailed history of Koss Olinger Consulting, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Koss Olinger Consulting, LLC holds 3,035 shares of ABT stock, worth $341,134. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,035
Previous 44,335 93.15%
Holding current value
$341,134
Previous $5.04 Million 93.75%
% of portfolio
0.03%
Previous 2.86%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$100.73 - $112.44 $4.16 Million - $4.64 Million
-41,300 Reduced 93.15%
3,035 $315,000
Q1 2024

Apr 17, 2024

BUY
$109.52 - $120.96 $4.41 Million - $4.87 Million
40,276 Added 992.26%
44,335 $5.04 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $5,862 - $7,176
65 Added 1.63%
4,059 $446,000
Q3 2023

Oct 10, 2023

SELL
$95.53 - $114.62 $49,389 - $59,258
-517 Reduced 11.46%
3,994 $386,000
Q2 2023

Jul 28, 2023

BUY
$100.78 - $112.29 $6,752 - $7,523
67 Added 1.51%
4,511 $491,000
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $36,709 - $43,209
379 Added 9.32%
4,444 $449,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $46,959 - $55,090
494 Added 13.83%
4,065 $446,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $77,891 - $90,184
805 Added 29.1%
3,571 $346,000
Q2 2022

Jul 08, 2022

SELL
$102.07 - $123.37 $8,675 - $10,486
-85 Reduced 2.98%
2,766 $301,000
Q1 2022

May 06, 2022

SELL
$114.02 - $139.04 $59,290 - $72,300
-520 Reduced 15.43%
2,851 $337,000
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $118,995 - $145,703
1,030 Added 44.0%
3,371 $474,000
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $2,449 - $2,710
21 Added 0.91%
2,341 $277,000
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $17,666 - $20,796
167 Added 7.76%
2,320 $269,000
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $234,332 - $276,079
2,153 New
2,153 $258,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Koss Olinger Consulting, LLC Portfolio

Follow Koss Olinger Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Koss Olinger Consulting, LLC with notifications on news.